Natera co-founder sells $89,555 worth of company stock By Investing.com



In a recent transaction, Sheena Jonathan, co-founder of Natera, Inc. (NASDAQ: ), a leader in personalized genetic testing and diagnostics, sold a total of $89,550 in the company's stock. The transaction took place on April 25, 2024, at a uniform price of $89.55 per share.

The sale was conducted through two separate trusts called the Caraluna 1 Trust and the Caraluna 2 Trust, both of which hold the stock indirectly for the benefit of Jonathan's minor children. According to the filing, Jonathan denies beneficial ownership of the shares. It is worth noting that the sale was conducted under the Rule 10b5-1 Exchange Plan adopted on March 13, 2023.

After the sale, the remaining number of Natera shares directly held by Jonathan reached 321,364 shares. Executing this sale under a prearranged trading plan allows insiders to sell their shares at predetermined times to avoid any accusation of trading on material non-public information.

Investors who monitor insider trading often keep a close eye on such sales because they provide an insider's view on the value of a company's shares. However, it's also common for insiders to sell shares for personal financial management reasons, which doesn't necessarily indicate a lack of confidence in a company's future prospects.

Natera has been at the forefront of genetic testing, offering a range of products from non-invasive prenatal testing to cancer screening. The company's stock performance is closely watched by investors interested in the healthcare and biotech industries.

Investment Professional Insights

In light of recent insider transactions, investors may look to broader company metrics and performance measures to measure Natra Corporation market position. According to InvestingPro, Natera has strong revenue growth, growing 31.99% in the past 12 months to the fourth quarter of 2023, and its quarterly revenue growth in the first quarter of 2023 was even more impressive, reaching 43.2%. The company's revenue growth is strong.

3rd party advertising. Not an offer or recommendation by Investing.com.See disclosures here or
Remove ads
.

The company's shares have surged despite not making a profit in the last twelve months, with a price-to-earnings ratio of -24.25 and an adjusted price-to-earnings ratio of -25.77. The one-year price total return is an impressive 82.48%, with the stock currently trading near its 52-week high at 92.75% of the value. This is consistent with InvestingPro Tips, which highlights Natera's strong returns over the last year and its substantial price gains over the past six months.

For investors considering Natera's liquidity and debt, the company has moderate debt levels and has liquid assets that exceed its short-term debt. These factors can provide some assurance about the company's ability to meet its financial commitments in the short term. For those interested in taking a deeper look at the company's financial health and future prospects, there are additional InvestingPro Tips available, which provide some insights, such as the fact that the company trades at a high price-to-book ratio of 14.64 and its long-term return potential.

Investors looking to take advantage of these insights and more can explore Natera Inc's full suite of InvestingPro tips at https://www.investing.com/pro/NTRA and take advantage of special offers using coupon codes PRONEWS24 Annual or biennial Pro and Pro+ subscriptions receive an additional 10% discount.

This article was generated with the support of artificial intelligence and reviewed by an editor. For more information, please see our terms and conditions.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *